Economic Burden Associated with Negative Symptoms Identified Through Natural Language Processing Among Patients with Schizophrenia in the United States.

Jerome Vaccaro¹, Mona Nili², Pin Xiang², James K Nelson³, Cory Pack³, Randall Thompson³, Joe Vasey³, Joseph Parks⁴

¹RightPath HC, Millerton, NY 12546, United States.

²Boehringer Ingelheim Pharmaceutical Inc, Ridgefield, CT 06877, United States.

³Veradigm Health, Raleigh, NC 27609, United States.

⁴National Council for Behavioral Wellbeing, Washington, DC 20005, United States.

PubMed PMC DOI PDF

Abstract

BACKGROUND AND HYPOTHESIS: The objective of this study was to identify documented negative symptoms of schizophrenia using natural language processing (NLP) and to characterize treatment patterns, healthcare resource utilization (HCRU), and costs among this patient population. STUDY DESIGN: This US retrospective cohort study used electronic health records (EHR) linked to administrative claims dat…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.